Overview
Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women
Status:
Completed
Completed
Trial end date:
2011-11-01
2011-11-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this study is to compare the efficacy of the Levonorgestrel releasing Intrauterine System (Mirena) and Norethisterone Acetate for treatment of non-atypical endometrial hyperplasia in perimenopausal women.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Mansoura UniversityTreatments:
Levonorgestrel
Norethindrone
Norethindrone Acetate
Criteria
Inclusion Criteria:- Patients with histologically confirmed simple or complex endometrial hyperplasia
without atypia
Exclusion Criteria:
- Endometrial hyperplasia with atypia
- Other pathology e.g. patients with fibroids of any size, genital infection, adnexal
abnormality.